Advanced Medical Isotopes Corporation Announces Board of Directors Appointment
Published: Sep 11, 2012
KENNEWICK, Wash., Sept. 11, 2012 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, has added one of the region's top medical device entrepreneurs, Thomas J. Clement, to the Board of Directors. Clement has over 30 years experience in product development engineering, engineering management, and senior management. He was a founding employee of Heart Technology, which grew to more than $100 million in revenue and was acquired by Boston Scientific. In 1998 Clement co-founded Pathway Medical Technologies, Inc. Serving as CEO, he successfully raised more than $84 million. Pathway was acquired by Bayer Healthcare of Germany in 2011.